Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Neuroendoscopy Market by Product (Rigid, Rigid Videoscopes, Rigid Fiberscopes, Flexible), by Application (Transnasal, Intraventricular, Transcranial), by Usability (Reusable, Disposable) and by End Users (Hospitals, Ambulatory surgical centers, Diagnostic centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A09088

Pages: NA

Charts: NA

Tables: NA

Neuroendoscopy Market Outlook - 2027

Neuroendoscopy market size is expected to grow in upcoming years due to factors such as rise in prevalence of neurological disorders and increase in favorable initiatives taken by the government regarding neuroendoscopy. Advantages of neuroendoscopy over conventional brain surgery is boosting the growth for the market.

Neuroendoscopy procedure refers endoscopy of brain in which samples of brain tissue are taken for diagnosis, removal of fluid, excision of tumors from the brain. During the procedure the endoscopy instruments are inserted into the skull, mouth or nose through small incisions. Some of the diseases which can be treated with the help of neuroendoscopy are skull base, acoustic neuromas, hydrocephalus, colloid and arachnoid cysts and tumors pf pituitary. During neuroendoscopy procedure a tiny telescopic device with a high- resolution video camera is used for endoscopy. With use of neuroendoscopy different parts of brain can be navigated which are not diagnosed by traditional surgery. 

COVID-19 scenario analysis:

To take care of infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Considering these factors, COVID -19 is expected to have significant impact on Neuroendoscopy Market.

Top Impacting factors:

  • Factors such as rise in prevalence of neurological disorders and increase in technological advancements in field of endoscopy is expected to drive the growth for neuroendoscopy market.
  • Favorable initiatives taken by the government and advantages of neuroendoscopy as compared to traditional surgery is expected to boost the market growth.
  • Rise in demand for neuroendoscopy due to increase in awareness and its advantages such as less pain, fast recovery and minimal scarring has resulted in growth for the neuroendoscopy market.
  • However, high costs associated with neuroendoscopy procedure and equipment and downward pricing pressure is expected to hamper the growth of neuroendoscopu market up to some extent over the forecast period.

New Product Launch / News:

  • In 2019, With the launch of advanced neurosurgical unit, Kauvery Hospital will be at the forefront for providing cutting-edge neurology treatment. Unit is equipped newly unveiled 3D microscope and robotic surgical device
  • In 2018, KARL STORZ Launched New 4 mm Endoscopic NIR/ICG Fluorescence Imaging System to Enhance Minimally Invasive Neurosurgery. The KARL STORZ NIR/ICG Imaging System enables live visualization of structural landmarks beneath the tissue surface, with no latency, using near-infrared (NIR) imaging to detect indocyanine green (ICG), an optical imaging agent administered to the patient during the procedure.

Key benefits of the report:

  • This study presents the analytical depiction of the Neuroendoscopy Market along with the current trends and future estimations to determine the investments.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Market share.
  • The current Neuroendoscopy market is quantitatively analyzed to highlight the Market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed Neuroendoscopy Market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Neuroendoscopy Market Report:

  • What are the leading market players active in Neuroendoscopy Market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
  • What Segments and region will drive the market growth & why?

Key Market Segments

  • By Product
    • Rigid
    • Rigid Videoscopes
    • Rigid Fiberscopes
    • Flexible
  • By Application
    • Transnasal
    • Intraventricular
    • Transcranial
  • By Usability
    • Reusable
    • Disposable
  • By End Users
    • Hospitals
    • Ambulatory surgical centers
    • Diagnostic centers
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • LocaMed
  • Hangzhou Hawk Optical Electronic Instruments
  • Tonglu Wanhe Medical Instrument
  • Ackermann Instrumente
  • KARL STORZ
  • Machida Endoscope
  • Adeor Medical
  • FUJIFILM Holding Corporation.
  • B. Braun
  • Visionsense Corporation
  • Schindler Endoskopie
  • Clarus Medical
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: NEUROENDOSCOPY MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Rigid

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Rigid Videoscopes

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Rigid Fiberscopes

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Flexible

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: NEUROENDOSCOPY MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Transnasal

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Intraventricular

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Transcranial

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: NEUROENDOSCOPY MARKET, BY USABILITY

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Usability

    • 6.2. Reusable

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Disposable

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: NEUROENDOSCOPY MARKET, BY END USERS

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End Users

    • 7.2. Hospitals

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Ambulatory Surgical Centers

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Diagnostic Centers

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Others

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: NEUROENDOSCOPY MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Product

      • 8.2.3. Market Size and Forecast, By Application

      • 8.2.4. Market Size and Forecast, By Usability

      • 8.2.5. Market Size and Forecast, By End Users

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Neuroendoscopy Market

        • 8.2.7.1. Market Size and Forecast, By Product
        • 8.2.7.2. Market Size and Forecast, By Application
        • 8.2.7.3. Market Size and Forecast, By Usability
        • 8.2.7.4. Market Size and Forecast, By End Users
      • 8.2.8. Canada Neuroendoscopy Market

        • 8.2.8.1. Market Size and Forecast, By Product
        • 8.2.8.2. Market Size and Forecast, By Application
        • 8.2.8.3. Market Size and Forecast, By Usability
        • 8.2.8.4. Market Size and Forecast, By End Users
      • 8.2.9. Mexico Neuroendoscopy Market

        • 8.2.9.1. Market Size and Forecast, By Product
        • 8.2.9.2. Market Size and Forecast, By Application
        • 8.2.9.3. Market Size and Forecast, By Usability
        • 8.2.9.4. Market Size and Forecast, By End Users
    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Product

      • 8.3.3. Market Size and Forecast, By Application

      • 8.3.4. Market Size and Forecast, By Usability

      • 8.3.5. Market Size and Forecast, By End Users

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Neuroendoscopy Market

        • 8.3.7.1. Market Size and Forecast, By Product
        • 8.3.7.2. Market Size and Forecast, By Application
        • 8.3.7.3. Market Size and Forecast, By Usability
        • 8.3.7.4. Market Size and Forecast, By End Users
      • 8.3.8. Germany Neuroendoscopy Market

        • 8.3.8.1. Market Size and Forecast, By Product
        • 8.3.8.2. Market Size and Forecast, By Application
        • 8.3.8.3. Market Size and Forecast, By Usability
        • 8.3.8.4. Market Size and Forecast, By End Users
      • 8.3.9. Italy Neuroendoscopy Market

        • 8.3.9.1. Market Size and Forecast, By Product
        • 8.3.9.2. Market Size and Forecast, By Application
        • 8.3.9.3. Market Size and Forecast, By Usability
        • 8.3.9.4. Market Size and Forecast, By End Users
      • 8.3.10. Spain Neuroendoscopy Market

        • 8.3.10.1. Market Size and Forecast, By Product
        • 8.3.10.2. Market Size and Forecast, By Application
        • 8.3.10.3. Market Size and Forecast, By Usability
        • 8.3.10.4. Market Size and Forecast, By End Users
      • 8.3.11. UK Neuroendoscopy Market

        • 8.3.11.1. Market Size and Forecast, By Product
        • 8.3.11.2. Market Size and Forecast, By Application
        • 8.3.11.3. Market Size and Forecast, By Usability
        • 8.3.11.4. Market Size and Forecast, By End Users
      • 8.3.12. Russia Neuroendoscopy Market

        • 8.3.12.1. Market Size and Forecast, By Product
        • 8.3.12.2. Market Size and Forecast, By Application
        • 8.3.12.3. Market Size and Forecast, By Usability
        • 8.3.12.4. Market Size and Forecast, By End Users
      • 8.3.13. Rest Of Europe Neuroendoscopy Market

        • 8.3.13.1. Market Size and Forecast, By Product
        • 8.3.13.2. Market Size and Forecast, By Application
        • 8.3.13.3. Market Size and Forecast, By Usability
        • 8.3.13.4. Market Size and Forecast, By End Users
    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Product

      • 8.4.3. Market Size and Forecast, By Application

      • 8.4.4. Market Size and Forecast, By Usability

      • 8.4.5. Market Size and Forecast, By End Users

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Neuroendoscopy Market

        • 8.4.7.1. Market Size and Forecast, By Product
        • 8.4.7.2. Market Size and Forecast, By Application
        • 8.4.7.3. Market Size and Forecast, By Usability
        • 8.4.7.4. Market Size and Forecast, By End Users
      • 8.4.8. Japan Neuroendoscopy Market

        • 8.4.8.1. Market Size and Forecast, By Product
        • 8.4.8.2. Market Size and Forecast, By Application
        • 8.4.8.3. Market Size and Forecast, By Usability
        • 8.4.8.4. Market Size and Forecast, By End Users
      • 8.4.9. India Neuroendoscopy Market

        • 8.4.9.1. Market Size and Forecast, By Product
        • 8.4.9.2. Market Size and Forecast, By Application
        • 8.4.9.3. Market Size and Forecast, By Usability
        • 8.4.9.4. Market Size and Forecast, By End Users
      • 8.4.10. South Korea Neuroendoscopy Market

        • 8.4.10.1. Market Size and Forecast, By Product
        • 8.4.10.2. Market Size and Forecast, By Application
        • 8.4.10.3. Market Size and Forecast, By Usability
        • 8.4.10.4. Market Size and Forecast, By End Users
      • 8.4.11. Australia Neuroendoscopy Market

        • 8.4.11.1. Market Size and Forecast, By Product
        • 8.4.11.2. Market Size and Forecast, By Application
        • 8.4.11.3. Market Size and Forecast, By Usability
        • 8.4.11.4. Market Size and Forecast, By End Users
      • 8.4.12. Thailand Neuroendoscopy Market

        • 8.4.12.1. Market Size and Forecast, By Product
        • 8.4.12.2. Market Size and Forecast, By Application
        • 8.4.12.3. Market Size and Forecast, By Usability
        • 8.4.12.4. Market Size and Forecast, By End Users
      • 8.4.13. Malaysia Neuroendoscopy Market

        • 8.4.13.1. Market Size and Forecast, By Product
        • 8.4.13.2. Market Size and Forecast, By Application
        • 8.4.13.3. Market Size and Forecast, By Usability
        • 8.4.13.4. Market Size and Forecast, By End Users
      • 8.4.14. Indonesia Neuroendoscopy Market

        • 8.4.14.1. Market Size and Forecast, By Product
        • 8.4.14.2. Market Size and Forecast, By Application
        • 8.4.14.3. Market Size and Forecast, By Usability
        • 8.4.14.4. Market Size and Forecast, By End Users
      • 8.4.15. Rest of Asia Pacific Neuroendoscopy Market

        • 8.4.15.1. Market Size and Forecast, By Product
        • 8.4.15.2. Market Size and Forecast, By Application
        • 8.4.15.3. Market Size and Forecast, By Usability
        • 8.4.15.4. Market Size and Forecast, By End Users
    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Product

      • 8.5.3. Market Size and Forecast, By Application

      • 8.5.4. Market Size and Forecast, By Usability

      • 8.5.5. Market Size and Forecast, By End Users

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Neuroendoscopy Market

        • 8.5.7.1. Market Size and Forecast, By Product
        • 8.5.7.2. Market Size and Forecast, By Application
        • 8.5.7.3. Market Size and Forecast, By Usability
        • 8.5.7.4. Market Size and Forecast, By End Users
      • 8.5.8. South Africa Neuroendoscopy Market

        • 8.5.8.1. Market Size and Forecast, By Product
        • 8.5.8.2. Market Size and Forecast, By Application
        • 8.5.8.3. Market Size and Forecast, By Usability
        • 8.5.8.4. Market Size and Forecast, By End Users
      • 8.5.9. Saudi Arabia Neuroendoscopy Market

        • 8.5.9.1. Market Size and Forecast, By Product
        • 8.5.9.2. Market Size and Forecast, By Application
        • 8.5.9.3. Market Size and Forecast, By Usability
        • 8.5.9.4. Market Size and Forecast, By End Users
      • 8.5.10. UAE Neuroendoscopy Market

        • 8.5.10.1. Market Size and Forecast, By Product
        • 8.5.10.2. Market Size and Forecast, By Application
        • 8.5.10.3. Market Size and Forecast, By Usability
        • 8.5.10.4. Market Size and Forecast, By End Users
      • 8.5.11. Argentina Neuroendoscopy Market

        • 8.5.11.1. Market Size and Forecast, By Product
        • 8.5.11.2. Market Size and Forecast, By Application
        • 8.5.11.3. Market Size and Forecast, By Usability
        • 8.5.11.4. Market Size and Forecast, By End Users
      • 8.5.12. Rest of LAMEA Neuroendoscopy Market

        • 8.5.12.1. Market Size and Forecast, By Product
        • 8.5.12.2. Market Size and Forecast, By Application
        • 8.5.12.3. Market Size and Forecast, By Usability
        • 8.5.12.4. Market Size and Forecast, By End Users
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning, 2024

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. KARL STORZ

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Ackermann Instrumente

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Adeor Medical

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. B. Braun

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Hangzhou Hawk Optical Electronic Instruments

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Machida Endoscope

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Tonglu Wanhe Medical Instrument

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Schindler Endoskopie

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Clarus Medical

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. LocaMed

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

    • 10.11. Visionsense Corporation

      • 10.11.1. Company Overview

      • 10.11.2. Key Executives

      • 10.11.3. Company Snapshot

      • 10.11.4. Operating Business Segments

      • 10.11.5. Product Portfolio

      • 10.11.6. Business Performance

      • 10.11.7. Key Strategic Moves and Developments

    • 10.12. FUJIFILM Holding Corporation.

      • 10.12.1. Company Overview

      • 10.12.2. Key Executives

      • 10.12.3. Company Snapshot

      • 10.12.4. Operating Business Segments

      • 10.12.5. Product Portfolio

      • 10.12.6. Business Performance

      • 10.12.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEUROENDOSCOPY MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL NEUROENDOSCOPY MARKET FOR RIGID, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL NEUROENDOSCOPY MARKET FOR RIGID VIDEOSCOPES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL NEUROENDOSCOPY MARKET FOR RIGID FIBERSCOPES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL NEUROENDOSCOPY MARKET FOR FLEXIBLE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL NEUROENDOSCOPY MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL NEUROENDOSCOPY MARKET FOR TRANSNASAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL NEUROENDOSCOPY MARKET FOR INTRAVENTRICULAR, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL NEUROENDOSCOPY MARKET FOR TRANSCRANIAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL NEUROENDOSCOPY MARKET, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL NEUROENDOSCOPY MARKET FOR REUSABLE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL NEUROENDOSCOPY MARKET FOR DISPOSABLE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL NEUROENDOSCOPY MARKET, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL NEUROENDOSCOPY MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL NEUROENDOSCOPY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL NEUROENDOSCOPY MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL NEUROENDOSCOPY MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL NEUROENDOSCOPY MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA NEUROENDOSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. NORTH AMERICA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 23. NORTH AMERICA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 24. U.S. NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. U.S. NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. U.S. NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 27. U.S. NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 28. CANADA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 29. CANADA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. CANADA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 31. CANADA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 32. MEXICO NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 33. MEXICO NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. MEXICO NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 35. MEXICO NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 36. EUROPE NEUROENDOSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 37. EUROPE NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. EUROPE NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. EUROPE NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 40. EUROPE NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 41. FRANCE NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 42. FRANCE NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 43. FRANCE NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 44. FRANCE NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 45. GERMANY NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 46. GERMANY NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. GERMANY NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 48. GERMANY NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 49. ITALY NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. ITALY NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. ITALY NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 52. ITALY NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 53. SPAIN NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 54. SPAIN NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. SPAIN NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 56. SPAIN NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 57. UK NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 58. UK NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. UK NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 60. UK NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 61. RUSSIA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 62. RUSSIA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. RUSSIA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 64. RUSSIA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 65. REST OF EUROPE NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. REST OF EUROPE NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. REST OF EUROPE NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 68. REST OF EUROPE NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 69. ASIA-PACIFIC NEUROENDOSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 70. ASIA-PACIFIC NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 71. ASIA-PACIFIC NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. ASIA-PACIFIC NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 73. ASIA-PACIFIC NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 74. CHINA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 75. CHINA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. CHINA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 77. CHINA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 78. JAPAN NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 79. JAPAN NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 80. JAPAN NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 81. JAPAN NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 82. INDIA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 83. INDIA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 84. INDIA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 85. INDIA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 86. SOUTH KOREA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 87. SOUTH KOREA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 88. SOUTH KOREA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH KOREA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 90. AUSTRALIA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 91. AUSTRALIA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 92. AUSTRALIA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 93. AUSTRALIA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 94. THAILAND NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 95. THAILAND NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 96. THAILAND NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 97. THAILAND NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 98. MALAYSIA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 99. MALAYSIA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 100. MALAYSIA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 101. MALAYSIA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 102. INDONESIA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 103. INDONESIA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 104. INDONESIA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 105. INDONESIA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 106. REST OF ASIA PACIFIC NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 107. REST OF ASIA PACIFIC NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 108. REST OF ASIA PACIFIC NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 110. LAMEA NEUROENDOSCOPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 111. LAMEA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 112. LAMEA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 113. LAMEA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 114. LAMEA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 115. BRAZIL NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 116. BRAZIL NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 117. BRAZIL NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 118. BRAZIL NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 119. SOUTH AFRICA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 120. SOUTH AFRICA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 121. SOUTH AFRICA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 122. SOUTH AFRICA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 123. SAUDI ARABIA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 124. SAUDI ARABIA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 125. SAUDI ARABIA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 126. SAUDI ARABIA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 127. UAE NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 128. UAE NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 129. UAE NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 130. UAE NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 131. ARGENTINA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 132. ARGENTINA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 133. ARGENTINA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 134. ARGENTINA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 135. REST OF LAMEA NEUROENDOSCOPY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 136. REST OF LAMEA NEUROENDOSCOPY, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 137. REST OF LAMEA NEUROENDOSCOPY, BY USABILITY, 2025-2033 ($MILLION)
  • TABLE 138. REST OF LAMEA NEUROENDOSCOPY, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 139. KARL STORZ: KEY EXECUTIVES
  • TABLE 140. KARL STORZ: COMPANY SNAPSHOT
  • TABLE 141. KARL STORZ: OPERATING SEGMENTS
  • TABLE 142. KARL STORZ: PRODUCT PORTFOLIO
  • TABLE 143. KARL STORZ: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. ACKERMANN INSTRUMENTE: KEY EXECUTIVES
  • TABLE 145. ACKERMANN INSTRUMENTE: COMPANY SNAPSHOT
  • TABLE 146. ACKERMANN INSTRUMENTE: OPERATING SEGMENTS
  • TABLE 147. ACKERMANN INSTRUMENTE: PRODUCT PORTFOLIO
  • TABLE 148. ACKERMANN INSTRUMENTE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. ADEOR MEDICAL: KEY EXECUTIVES
  • TABLE 150. ADEOR MEDICAL: COMPANY SNAPSHOT
  • TABLE 151. ADEOR MEDICAL: OPERATING SEGMENTS
  • TABLE 152. ADEOR MEDICAL: PRODUCT PORTFOLIO
  • TABLE 153. ADEOR MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. B. BRAUN: KEY EXECUTIVES
  • TABLE 155. B. BRAUN: COMPANY SNAPSHOT
  • TABLE 156. B. BRAUN: OPERATING SEGMENTS
  • TABLE 157. B. BRAUN: PRODUCT PORTFOLIO
  • TABLE 158. B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: KEY EXECUTIVES
  • TABLE 160. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: COMPANY SNAPSHOT
  • TABLE 161. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: OPERATING SEGMENTS
  • TABLE 162. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: PRODUCT PORTFOLIO
  • TABLE 163. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 164. MACHIDA ENDOSCOPE: KEY EXECUTIVES
  • TABLE 165. MACHIDA ENDOSCOPE: COMPANY SNAPSHOT
  • TABLE 166. MACHIDA ENDOSCOPE: OPERATING SEGMENTS
  • TABLE 167. MACHIDA ENDOSCOPE: PRODUCT PORTFOLIO
  • TABLE 168. MACHIDA ENDOSCOPE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 169. TONGLU WANHE MEDICAL INSTRUMENT: KEY EXECUTIVES
  • TABLE 170. TONGLU WANHE MEDICAL INSTRUMENT: COMPANY SNAPSHOT
  • TABLE 171. TONGLU WANHE MEDICAL INSTRUMENT: OPERATING SEGMENTS
  • TABLE 172. TONGLU WANHE MEDICAL INSTRUMENT: PRODUCT PORTFOLIO
  • TABLE 173. TONGLU WANHE MEDICAL INSTRUMENT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 174. SCHINDLER ENDOSKOPIE: KEY EXECUTIVES
  • TABLE 175. SCHINDLER ENDOSKOPIE: COMPANY SNAPSHOT
  • TABLE 176. SCHINDLER ENDOSKOPIE: OPERATING SEGMENTS
  • TABLE 177. SCHINDLER ENDOSKOPIE: PRODUCT PORTFOLIO
  • TABLE 178. SCHINDLER ENDOSKOPIE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 179. CLARUS MEDICAL: KEY EXECUTIVES
  • TABLE 180. CLARUS MEDICAL: COMPANY SNAPSHOT
  • TABLE 181. CLARUS MEDICAL: OPERATING SEGMENTS
  • TABLE 182. CLARUS MEDICAL: PRODUCT PORTFOLIO
  • TABLE 183. CLARUS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 184. LOCAMED: KEY EXECUTIVES
  • TABLE 185. LOCAMED: COMPANY SNAPSHOT
  • TABLE 186. LOCAMED: OPERATING SEGMENTS
  • TABLE 187. LOCAMED: PRODUCT PORTFOLIO
  • TABLE 188. LOCAMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 189. VISIONSENSE CORPORATION: KEY EXECUTIVES
  • TABLE 190. VISIONSENSE CORPORATION: COMPANY SNAPSHOT
  • TABLE 191. VISIONSENSE CORPORATION: OPERATING SEGMENTS
  • TABLE 192. VISIONSENSE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 193. VISIONSENSE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 194. FUJIFILM HOLDING CORPORATION.: KEY EXECUTIVES
  • TABLE 195. FUJIFILM HOLDING CORPORATION.: COMPANY SNAPSHOT
  • TABLE 196. FUJIFILM HOLDING CORPORATION.: OPERATING SEGMENTS
  • TABLE 197. FUJIFILM HOLDING CORPORATION.: PRODUCT PORTFOLIO
  • TABLE 198. FUJIFILM HOLDING CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROENDOSCOPY MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEUROENDOSCOPY MARKET
  • FIGURE 3. SEGMENTATION NEUROENDOSCOPY MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEUROENDOSCOPY MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEUROENDOSCOPY MARKET
  • FIGURE 11. NEUROENDOSCOPY MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. NEUROENDOSCOPY MARKET FOR RIGID, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. NEUROENDOSCOPY MARKET FOR RIGID VIDEOSCOPES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. NEUROENDOSCOPY MARKET FOR RIGID FIBERSCOPES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. NEUROENDOSCOPY MARKET FOR FLEXIBLE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. NEUROENDOSCOPY MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 17. NEUROENDOSCOPY MARKET FOR TRANSNASAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. NEUROENDOSCOPY MARKET FOR INTRAVENTRICULAR, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. NEUROENDOSCOPY MARKET FOR TRANSCRANIAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. NEUROENDOSCOPY MARKET SEGMENTATION, BY BY USABILITY
  • FIGURE 21. NEUROENDOSCOPY MARKET FOR REUSABLE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. NEUROENDOSCOPY MARKET FOR DISPOSABLE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. NEUROENDOSCOPY MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 24. NEUROENDOSCOPY MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. NEUROENDOSCOPY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. NEUROENDOSCOPY MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. NEUROENDOSCOPY MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 28. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 29. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 30. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 31. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 32. COMPETITIVE DASHBOARD
  • FIGURE 33. COMPETITIVE HEATMAP: NEUROENDOSCOPY MARKET
  • FIGURE 34. TOP PLAYER POSITIONING, 2024
  • FIGURE 35. KARL STORZ: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. KARL STORZ: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. KARL STORZ: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. ACKERMANN INSTRUMENTE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. ACKERMANN INSTRUMENTE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. ACKERMANN INSTRUMENTE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. ADEOR MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. ADEOR MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. ADEOR MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. B. BRAUN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. B. BRAUN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. B. BRAUN: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. MACHIDA ENDOSCOPE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. MACHIDA ENDOSCOPE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. MACHIDA ENDOSCOPE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. TONGLU WANHE MEDICAL INSTRUMENT: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. TONGLU WANHE MEDICAL INSTRUMENT: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. TONGLU WANHE MEDICAL INSTRUMENT: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. SCHINDLER ENDOSKOPIE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. SCHINDLER ENDOSKOPIE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. SCHINDLER ENDOSKOPIE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. CLARUS MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. CLARUS MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. CLARUS MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 62. LOCAMED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 63. LOCAMED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 64. LOCAMED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 65. VISIONSENSE CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 66. VISIONSENSE CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 67. VISIONSENSE CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 68. FUJIFILM HOLDING CORPORATION.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 69. FUJIFILM HOLDING CORPORATION.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 70. FUJIFILM HOLDING CORPORATION.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Neuroendoscopy Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue